Singapore, Nov. 25 -- South Korea-based Neurophet, an artificial intelligence (AI) solution startup for brain disorders diagnosis and treatment, is collaborating with the Florey Institute of Neuroscience and Mental Health (The Florey) in Australia on joint research using its brain neurodegeneration imaging analysis software, Neurophet AQUA.

This collaborative study, titled "Enhanced Dementia Diagnosis (EDD) in Australian Memory Clinics," aims to evaluate the utility of blood-based and other biomarkers in the diagnosis and management of Alzheimer's disease in a real-world clinical setting, including Neurophet's AQUA software. Through this initiative, both parties will accelerate their research collaboration to advance high-precision demen...